MGMA weighs in on prior authorization reform in new letter to CMS

The Medical Group Management Association, a network of over 60,000 medical group leaders, submitted a Feb. 10 letter to CMS weighing in on several key issues for 2023, including prior authorization reform and prescription drug prices. 

Advertisement

Here are some of MGMA’s key requests: 

1.  Finalize previously proposed prior authorization rules to lessen medical provider burdens. 

2. Apply clinical validity and transparency coverage criteria policies to include prescription drug costs. 

3. Establish oversight to hold plans accountable for noncompliance. 

4. Include additional prior authorization reforms in future lawmaking. 

5. Ensure Medicare and Medicaid both have access to the same items and services. 

6. Finalize prior authorization rules allowing patients guaranteed continuity of care. 

7. Reinstate the step therapy prohibition in Medicare Advantage plans for Part B medications. 

8. Develop gold-carding programs with stakeholders for Medicare Advantage plans. 

9. Waive prior authorization requirements for providers in value-based care models. 

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Advertisement

Next Up in News

Advertisement

Comments are closed.